Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes☆
To access this article, please choose from the options below
☆ Supported in part by a grant from Lilly Industries (A.P.) and a grant from the British Diabetic Association (C.A.).
PII: S0026-0495(98)90023-3
© 1998 Published by Elsevier Inc.
